Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Moderna, Inc.    MRNA


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Wall Street retreats, S&P 500 still set for best November ever

11/30/2020 | 10:57am EST

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)

* Dow on track for biggest monthly gain since 1987

* IHS Markit rises on $44 bln buyout deal from S&P Global

* Indexes down: Dow 0.9%, S&P 0.5%, Nasdaq 0.2%

Nov 30 (Reuters) - Wall Street's main indexes dipped on Monday as investors paused to take stock of a stellar month ahead of crucial economic reports this week.

Nine of the 11 major S&P 500 sectors were trading lower, with energy the biggest decliner in early trading. Oil majors including Exxon Mobil, Chevron and ConocoPhillips fell between 1.8% and 2.5%, tracking a decline in crude prices.

IHS Markit topped gains on the benchmark S&P 500 after data giant S&P Global agreed to buy the financial information provider in a $44 billion deal, which will be the biggest corporate acquisition of 2020.

Analysts said the month-end rebalancing of portfolios also played into on Monday's weakness as investors cash in on gains after a strong month marked by updates of COVID-19 vaccines making headway and hopes of a swift economic rebound next year.

A rotation into sectors deemed to provide better returns coming out of a recession such as energy, industrials and financials have powered the S&P 500 for its best November ever. The Dow is on track for its biggest monthly gain since 1987.

"Markets can, and have, looked through the strain that the virus' resurgence is putting on the economy through to a vaccine where the population can start to get back to normal," said Keith Buchanan, senior portfolio manager at GLOBALT in Atlanta.

"The question is if the market's forward looking mechanism is strong enough to outweigh what seems to be an unrelenting virus and the challenges it presents to the day-to-day activities of the economy."

At 10:13 a.m. ET, the Dow Jones Industrial Average fell 291.37 points, or 0.93% to 29,619.00 and the S&P 500 lost 17.63 points, or 0.48% to 3,622.08. The Nasdaq Composite lost 25.15 points, or 0.22% to 12,182.56 after hitting an all-time early in the session.

Technology and healthcare were the only two sectors trading higher.

U.S. Health Secretary Alex Azar on Monday said the first two vaccines against the novel coronavirus could be available to Americans before Christmas.

Moderna unveiled plans to apply for U.S. and European emergency authorization for its COVID-19 vaccine after full results from a late-stage study showed it was 94.1% effective, sending its shares up 16%.

After an explosion in infections and business restrictions this month that undermined the U.S. labor market recovery, focus will be on the monthly employment report and the Fed's Beige Book, as well as an address by Fed Chair Jerome Powell before the Senate Banking Committee.

Macy's Inc and Kohl's Corp slipped about 4% each as masked shoppers turned up in smaller numbers at major U.S. retailers on Black Friday as early online deals and concerns about a spike in COVID-19 cases dulled enthusiasm for mall trips.

Declining issues outnumbered advancers ones by 2-to-1 ratio on the NYSE and on Nasdaq a 0.6-to-1 ratio favored decliners.

The S&P 500 posted eight new 52-week highs and no new lows; the Nasdaq Composite recorded 222 new highs and five new lows. (Reporting by Shriya Ramakrishnan and Medha Singh in Bengaluru; Editing by Saumyadeb Chakrabarty and Arun Koyyur)

© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
DJ INDUSTRIAL -0.57% 30996.98 Delayed Quote.1.86%
MODERNA, INC. -1.47% 131.02 Delayed Quote.25.41%
NASDAQ 100 -0.29% 13366.396971 Delayed Quote.3.71%
NASDAQ COMP. 0.09% 13543.061633 Delayed Quote.4.99%
S&P 500 -0.30% 3841.47 Delayed Quote.2.27%
All news about MODERNA, INC.
01/23MODERNA : U.S. CDC says 41.4 mln doses of COVID-19 vaccines distributed, 20.5 ml..
01/22PFIZER : Provinces doing 'extraordinary' job to avoid wasting doses of COVID-19 ..
01/2239.9 MLN DOSES OF COVID-19 VACCINES : U.s. cdc
01/22CDC : 10 life-threatening reactions linked with Moderna COVID-19 vaccine
01/22MODERNA : Lucky few hit COVID-19 vaccine jackpot for rare extra doses
01/22MODERNA : Severe allergic reactions to Moderna vaccine appear rare -CDC report
01/22AstraZeneca's initial EU delivery volumes of COVID-19 vaccine to fall short
01/22MODERNA : BofA Securities Adjusts Moderna PT to $140 From $130, Maintains Neutra..
01/22Where Our Current Covid-19 Vaccination Rate Will Take Us
01/22Studies of South African Coronavirus Strain Raise Concerns About Immune Respo..
More news
Financials (USD)
Sales 2020 512 M - -
Net income 2020 -571 M - -
Net cash 2020 2 597 M - -
P/E ratio 2020 -107x
Yield 2020 -
Capitalization 51 846 M 51 846 M -
EV / Sales 2020 96,2x
EV / Sales 2021 4,40x
Nbr of Employees 1 100
Free-Float 90,0%
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 137,27 $
Last Close Price 131,02 $
Spread / Highest target 41,2%
Spread / Average Target 4,77%
Spread / Lowest Target -47,3%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
Noubar B. Afeyan Chairman
David W. Meline Chief Financial Officer
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capitalization (M$)
MODERNA, INC.25.41%51 846
LONZA GROUP AG5.34%50 271
CELLTRION, INC.-13.65%38 245
SEAGEN INC.4.35%33 059